Acne Relief Liquid
NDC Package 66096-168-05
Package Information
Acne Relief (antimonium crud, arsenicum brom, bovista, eugenia jamb, fluoricum acidum, hepar sulph calc, kali brom, kali iod, kali mur, nat brom, niccolum sulph, phosphoricum ac, sulphur iod.) liquids is classified as a
- increased large intestinal motility - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- potassium compounds - [cs]
- potassium salt - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- ANTIMONY TRISULFIDE 6 [hp_X]/59mL
- ARSENIC TRIBROMIDE 30 [hp_C]/59mL
- CALCIUM SULFIDE 30 [hp_C]/59mL
- HYDROFLUORIC ACID 30 [hp_C]/59mL
- LYCOPERDON UTRIFORME FRUITING BODY 30 [hp_C]/59mL
- NICKEL SULFATE HEXAHYDRATE 4 [hp_X]/59mL
- PHOSPHORIC ACID 30 [hp_C]/59mL
- POTASSIUM BROMIDE 3 [hp_X]/59mL
- POTASSIUM CHLORIDE 6 [hp_X]/59mL
- POTASSIUM IODIDE 3 [hp_X]/59mL
- SODIUM BROMIDE 4 [hp_X]/59mL
- SULFUR IODIDE 14 [hp_X]/59mL
- SYZYGIUM JAMBOS SEED 14 [hp_X]/59mL
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 66096 - Ohm Pharma Inc.
- 66096-168 - Acne Relief
- 66096-168-05 - 59 mL in 1 PACKAGE
- 66096-168 - Acne Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66096-168-05 identifies a specific commercial package of 59 ml in 1 package of Acne Relief, a human over the counter drug labeled by Ohm Pharma Inc.. This liquid is formulated for oral use and contains antimony trisulfide; arsenic tribromide; calcium sulfide; hydrofluoric acid; lycoperdon utriforme fruiting body; nickel sulfate hexahydrate; phosphoric acid; potassium bromide; potassium chloride; potassium iodide; sodium bromide; sulfur iodide; syzygium jambos seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on May 21, 2015. The current certification is valid through December 31, 2026.
How is this Ohm Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096016805. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.